Evidence map›Paper›PMID 30014812›Full record

ArticleThe American journal of tropical medicine and hygiene2018

Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka.

Ramakrishna U Rao, Sandhya D Samarasekera, Kumara C Nagodavithana, Charles W Goss, Manjula W Punchihewa, Tharanga D M Dassanayaka, Udaya S B Ranasinghe, Devika Mendis, Gary J Weil

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Evaluating the Diagnostic Test Accuracy of Molecular Xenomonitoring Methods for Characterizing Community Burden of Lymphatic Filariasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Anti-filarial antibodies are sensitive indicators of lymphatic filariasis transmission and enable identification of high-risk populations and hotspots.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Lymphatic filariases and soil-transmitted helminthiases in Sri Lanka: the challenge of eliminating residual pockets of transmission.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  16. Article
  17. Article
  18. Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug ad ministration surveillance in American Samoa.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  19. The use of molecular xenomonitoring for surveillance of mosquito-borne diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ramakrishna U RaoDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Sandhya D SamarasekeraMinistry of Health, Anti-Filariasis Campaign, Colombo, Sri Lanka.
Kumara C NagodavithanaMinistry of Health, Anti-Filariasis Campaign, Colombo, Sri Lanka.
Charles W GossDivision of Biostatistics, Washington University School of Medicine, St. Louis, Missouri.
Manjula W PunchihewaRegional Anti-Filariasis Unit, Galle, Sri Lanka.
Tharanga D M DassanayakaMinistry of Health, Anti-Filariasis Campaign, Colombo, Sri Lanka.
Udaya S B RanasingheMinistry of Health, Anti-Filariasis Campaign, Colombo, Sri Lanka.
Devika MendisMinistry of Health, Anti-Filariasis Campaign, Colombo, Sri Lanka.
Gary J WeilDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Sri Lankan Anti-Filariasis campaign distributed five rounds of mass drug administration (MDA with diethylcarbamazine plus albendazole) to some 10 million people in eight districts between 2002 and 2006. Sri Lanka was recognized by the WHO for having eliminated lymphatic filariasis (LF) as a public health problem in 2016. However, recent studies by our group documented pockets with persistent LF in coastal Sri Lanka, especially in Galle district. The present study was performed to reexamine an area previously identified as a potential hotspot for persistent LF (Balapitiya Public Health Inspector area, population 17,500). A community survey documented high rates for circulating filarial antigenemia (3%, confidence interval [CI]: 1.8-4.9) and microfilaremia (1%, CI: 0.5-2.5%). Circulating filarial antigenemia rates were 2.8-fold higher in males than females. High prevalence was also observed for anti-filarial antibodies in young children (5.7%, CI: 3.7-8.4%) and for filarial DNA in vector mosquitoes (5.2%, CI: 4.2-6.3%). Spatial data showed that persistent LF was dispersed across the entire study area. Other studies showed that persistent LF was not limited to Balapitiya and not solved by additional rounds of MDA. Molecular xenomonitoring studies conducted in 2016 in 22 of 168 Public Health Midwife areas in the coastal Galle evaluation unit (approximate population 600,000) found that 179 of 660 (27%) pools of

Indexed as

AdolescentAdultAgedAlbendazoleAnimalsAnthelminticsAntibodies, HelminthChildCulexDiethylcarbamazineElephantiasis, FilarialFemaleHumansMaleMass Drug AdministrationMiddle AgedAlbendazoleAnthelminticsAntibodies, HelminthDiethylcarbamazine

Identifiers

PMID30014812
PMCPMC6169179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.